Skip to main content
PMC home page
European Journal of Human Genetics logoLink to European Journal of Human Genetics
. 2010 Dec 8;19(3):341–346. doi: 10.1038/ejhg.2010.178

Replication of genetic variants from genome-wide association studies with metabolic traits in an island population of the Adriatic coast of Croatia

Rebekah Karns 1, Ge Zhang 1,2, Nina Jeran 3, Dubravka Havas-Augustin 3, Sasa Missoni 3, Wen Niu 1, Subba Rao Indugula 1, Guangyun Sun 1, Zijad Durakovic 3, Nina Smolej Narancic 3, Pavao Rudan 3, Ranajit Chakraborty 4, Ranjan Deka 1,*
PMCID: PMC3061997  PMID: 21150882

Abstract

Twenty-two single-nucleotide polymorphisms (SNPs) in 10 gene regions previously identified in obesity and type 2 diabetes (T2D) genome-wide association studies (GWAS) were evaluated for association with metabolic traits in a sample from an island population of European descent. We performed a population-based study using 18 anthropometric and biochemical traits considered as continuous variables in a sample of 843 unrelated subjects (360 men and 483 women) aged 18–80 years old from the island of Hvar on the eastern Adriatic coast of Croatia. All eight GWAS SNPs in FTO were significantly associated with weight, body mass index, waist circumference and hip circumference; 20 of the 32 nominal P-values remained significant after permutation testing for multiple corrections. The strongest associations were found between the two TCF7L2 GWAS SNPs with fasting plasma glucose and HbA1c levels, all four P-values remained significant after permutation tests. Nominally significant associations were found between several SNPs and other metabolic traits; however, the significance did not hold after permutation tests. Although the sample size was modest, our study strongly replicated the association of FTO variants with obesity-related measures and TCF7L2 variants with T2D-related traits. The estimated effect sizes of these variants were larger or comparable to published studies. This is likely attributable to the homogenous genetic background of the relatively isolated study population.

Keywords: genetic association, obesity, type 2 diabetes, FTO, TCF7L2, isolated population

Introduction

Recent genome-wide association studies (GWAS) have identified nearly 30 common sequence variants associated with obesity and type 2 diabetes (T2D) related traits in populations primarily of European descent. Genes that have been implicated in T2D harboring these variants include TCF7L2, SLC30A8, HHEX/IDE, CDKAL1, CDKN2A/B, IGF2BP2, TCF2 and PPARG;1, 2, 3, 4, 5, 6, 7 genes that are primarily associated with obesity-related phenotypes are INSIG2, FTO, MC4R, BDNF and SH2B1.8, 9, 10, 11, 12, 13, 14 Among these genes, TCF7L2 and FTO have emerged as the strongest candidates conferring risks to T2D and obesity, respectively, replicated across studies with relatively large effect sizes.15, 16 The purpose of this study was to replicate a set of the significant GWAS single-nucleotide polymorphisms (SNPs) from the aforementioned studies with several metabolic traits in an island population from the eastern Adriatic coast of Croatia.

Croatian islanders are primarily of Slavic descent, who emigrated from the mainland at successive time periods, the latest during fifteenth and eighteenth century AD following the Turkish invasions.17, 18 Since that time, the populations have remained relatively isolated largely because of their geographic isolation with minimal immigration from the mainland. In spite of sharing a common descent, these populations are distinct from their mainland European ancestors, practicing a traditional life-style pattern based primarily on an agricultural subsistence in a rural setting and living on a typical ‘Mediterranean' diet of fish, vegetables, olive oil and red wine.18 However, previous studies have shown high prevalence of obesity and hypertension,19, 20, 21 which imply factors other than nutritional practices and life-style patterns have influenced variations in metabolic profiles of these populations.

We analyzed 22 significant GWAS SNPs located in and around INSIG2, PPARG, CDKAL1, SLC30A8, CDKN2A, CDKN2B, HHEX/IDE, TCF7L2, FTO and MC4R to test for associations with traits that include obesity-related measures of body mass index (BMI), waist circumference (WC), hip circumference (HC), waist–hip ratio (WHR), blood pressure and biochemical measures of fasting plasma glucose (FPG), HbA1c, insulin, HDL, LDL, total cholesterol (TC), triglyceride (TG), fibrinogen, calcium, creatinine and uric acid levels. Among the significant observations, we found strong associations of two SNPs (rs7903146 and rs12255372) in TCF7L2 with FPG and HbA1c levels; and all eight SNPs in FTO were individually associated with weight, BMI, WC and HC.

Materials and methods

Study population and phenotypic measurements

The study samples were collected from the island of Hvar, the largest of the middle Dalmatian islands on the Adriatic coast with a population of over 11 500 individuals. Anthropometric measurements of height (Ht), weight (Wt), WC, HC, blood pressure and blood samples were obtained from 843 unrelated individuals (360 men and 483 women) aged 18 to 80 years old from the island of Hvar. Subjects within this age bracket were randomly ascertained without consideration for any known disease status and use of medication. Study protocols were approved by the ethics committee of the Institute for Anthropological Research, Zagreb and the Institutional Review Board of the University of Cincinnati.

Data on Ht, Wt, WC and HC were used to compute the composite scores of BMI (Wt in kg)/(Ht in m2), and WHR (WC/HC). Blood pressure was measured three times using mercury sphygmomanometer at resting position; the second and the third measurements were used to calculate the mean systolic (SBP) and diastolic (DBP) blood pressure. Blood samples were drawn after a 12-h fast and serum was separated and kept frozen until shipped to the clinical chemistry laboratory in Zagreb, where biochemical tests were performed to measure FPG, HbA1c, insulin, HDL, LDL, TC, TG, fibrinogen, calcium, creatinine and uric acid levels using standard methods.

Genotyping

Twenty-two SNPs (Table 1) significantly associated with anthropometric and biochemical traits in GWAS were genotyped in the total sample of 843 subjects. The five MC4R SNPs were genotyped using the TaqMan assay and the remaining 17 SNPs were typed using the SNPlex assay following protocols described previously.22 Quality control was assured by introducing blind duplicates and negative controls into each batch of samples in the 96-well format. The overall genotype call rate of the 22 SNPs was 96.8% and the genotypic consistency rate based on 8 internal replicates was >99.5%.

Table 1. Summary of the studied GWAS SNPs.

NCBI SNP ID Gene Chromosome Positiona Study reference Ancestry of reference population Phenotype of reference study Allelesb HapMap caucasian MAF MAFc
rs7566605 INSIG2 2q14 1.19E+08 Herbert et al8 Western European African American Obesity CG 0.26 0.4
rs1801282 PPARG 3p25 12368125 WTCCC7 Western European T2D CG 0.10 0.16
rs10946398 CDKAL1 6p22 20769013 Zeggini et al4 Western European T2D AC 0.34 0.3
rs13266634 SLC30A8 8q24 1.18E+08 Sladek et al1 Western European T2D CT 0.24 0.36
rs564398 CDKN2B 9p21 22019547 Zeggini et al4 Western European T2D AG 0.43 0.39
rs10811661 CDKN2A 9p21 22124094 DGI3 Western European T2D TC 0.20 0.13
rs1111875 HHEX-IDE 10q23 94452862 Sladek et al1 Western European T2D GA 0.42 0.42
rs7903146 TCF7L2 10q25 1.15E+08 Grant et al29 Western European Obesity TC 0.28 0.29
rs12255372 TCF7L2 10q25 1.15E+08 Grant et al29 Western European Obesity GT 0.25 0.28
rs9939973 FTO 16q12 52358069 Hinney et al11 Western European Obesity GA 0.48 0.49
rs1421085 FTO 16q12 52358455 Dina et al10 Western European Obesity TC 0.46 0.47
rs1121980 FTO 16q12 52366748 Dina et al10 Western European Obesity CT 0.48 0.47
rs17817449 FTO 16q12 52370868 Dina et al10 Western European Obesity TG 0.46 0.44
rs8050136 FTO 16q12 52373776 Grant et al26 Western European Obesity CA 0.46 0.44
rs3751812 FTO 16q12 52375961 Dina et al10 Western European Obesity GT 0.46 0.44
rs9939609 FTO 16q12 52378028 Frayling et al9 Western European Obesity TA 0.46 0.43
rs7190492 FTO 16q12 52386253 Grant et al26 Western European Obesity GA 0.35 0.33
rs17782313 MC4R 18q22 56002077 Loos et al12 Western European Obesity TC 0.26 0.23
rs12970134 MC4R 18q22 56035730 Chambers et al13 Indian Asian, European T2D-related traitsd GA 0.28 0.22
rs477181 MC4R 18q22 56047018 Chambers et al13 Indian Asian, European T2D-related traitsd GT 0.34 0.33
rs502933 MC4R 18q22 56047454 Chambers et al13 Indian Asian, European T2D-related traitsd CA 0.34 0.34
rs4450508 MC4R 18q22 56064414 Chambers et al13 Indian Asian, European T2D-related traitsd GA 0.38 0.35
Open in a new tab
a

Chromosomal base position with reference to Human Genome Build 36.3.

b

Second nucleotide corresponds to the minor allele.

c

Minor allele frequency (MAF) in this study population.

d

HOMA-IR, WC, WHR, Wt, BMI, HDL, TG, DBP, T2D and metabolic syndrome.

Statistical analysis

Descriptive statistics of the phenotypic traits were calculated using SAS v.9. 1 (SAS Institute, Inc., Cary, NC, USA). Allele and genotype frequencies were computed using the HelixTree software (Golden Helix, Inc., Bozeman, MT, USA). Hardy–Weinberg equilibrium (HWE) was assessed by Fisher's exact test. The phenotypic traits were adjusted for the effects of age, gender and their interaction term by linear regression. The association between each SNP and the adjusted traits was performed using HelixTree based on an additive model (1 df test) with P-values considered nominally significant at ≤0.05. A permutation-based analysis, with 1 00 000 iterations, was performed to account for multiple tests based on the number of markers.

Results

Table 1 shows the description of the examined SNPs with their NCBI dbSNP IDs (‘rs' numbers), gene location, chromosomal base positions and minor allele frequencies (MAFs). Genotype proportions at all SNPs conformed to the expectations of HWE with a P-value >0.01 (data not shown). All of the SNPs in our population are moderately to highly polymorphic with the MAF ranging between 0.13 and 0.49. In general, the allele frequencies corresponded to those in the European HapMap sample (www.HapMap.org).

Descriptive statistics (mean±SD) of the phenotypic traits are presented in Table 2. The mean age of the participants at the time of sampling was 57.84 years (59.55 years in men and 56.56 years in women). All of the examined phenotypes were considered as continuous traits for analysis. Of the two classic measures of obesity, mean BMI was within the normal range of variation (BMI≤30 kg/m2) in both genders; however, mean WC was above the normal range as defined either by the ATPIII (Adult Treatment Panel III)23 or IDF (International Diabetes Federation)24 definitions in both men and women (men=101.9 cm, women=91.9 cm). Among the biochemical traits, mean FPG in men (6.3 mmol/l), TC in men (5.8 mmol/l) and women (6.1 mmol/l), and fibrinogen (3.6 g/l in men and 4.0 g/l in women) were slightly above the normal cutoff values. With an expected correlation of these measures with age, a likely explanation for this observation is the study group represents a relatively older population as indicated by the mean age of the participants.

Table 2. Summary statistics of the phenotypic traits.

  Male Female Total sample
Trait N Mean±SD Min Max N Mean±SD Min Max N Mean±SD Min Max
Age (year) 360 59.55±12.46 19.9 80 483 56.56±13.23 18.1 79.8 843 57.84±12.98 18.1 80
Ht (cm) 360 177.42±7.22 157.2 206 483 164.10±6.78 139 187.2 843 169.78±9.59 139 206
Wt (kg) 360 89.31±12.93 60.2 142.5 483 74.10±12.69 43 123.9 843 80.59±14.84 43 142.5
BMI (kg/m2) 360 28.32±3.34 19.64 42.23 483 27.54±4.58 16.7 45.79 843 27.87±4.11 16.7 45.79
WC (cm) 359 101.85±8.98 79.3 138.5 482 91.90±12.09 62.3 137.4 841 96.15±11.93 62.3 138.5
HC (cm) 360 104.42±7.29 90.8 132 482 106.15±10.46 75 150 842 105.41±9.27 75 150
WHR 359 0.97±0.05 0.727 1.124 482 0.86±0.06 0.651 1.12 841 0.91±0.08 0.651 1.124
DBP (mm Hg) 360 84.91±9.20 60 120 483 81.49±10.47 55 115 843 82.95±10.08 55 120
SBP (mm Hg) 360 138.59±20.56 100 240 483 132.42±24.46 90 230 843 135.05±23.07 90 240
FPG (mmol/l) 360 6.26±1.40 4.2 16.8 483 5.86±1.37 4.1 14.9 843 6.03±1.39 4.1 16.8
HbA1c (%) 360 5.78±0.84 4.6 12 482 5.77±0.87 4.7 12.4 842 5.77±0.86 4.6 12.4
Insulin (mmol/l) 360 11.15±8.13 1.15 72.26 482 11.383±7.93 1.3 56.26 842 11.28±8.01 1.15 72.26
HDL (mmol/l) 360 1.30±0.34 0.2 3.55 482 1.53±0.39 0.77 4.61 842 1.43±0.38 0.2 4.61
LDL (mmol/l) 358 3.68±0.95 1.1 6.7 481 3.91±1.04 1.2 8 839 3.81±1.01 1.1 8
TC (mmol/l) 360 5.80±1.10 2.4 9.1 482 6.09±1.22 1.5 10.4 842 5.971±1.18 1.5 10.4
TG (mmol/l) 360 1.70±1.03 0.36 6.31 482 1.41±0.75 0.33 5.09 842 1.53±0.89 0.33 6.31
Fibrinogen (mmol/l) 355 3.63±1.25 1.3 8.1 478 4.03±1.38 1.4 9.2 833 3.86±1.34 1.3 9.2
Calcium (mmol/l) 358 2.36±0.13 1.66 3.2 482 2.37±0.11 1.75 2.9 840 2.36±0.12 1.66 3.2
Creatinine (mmol/l) 360 97.68±20.94 54 280 482 78.84±12.99 48 141 842 86.89±19.26 48 280
Uric Acid (mmol/l) 359 365.89±80.58 169 671 482 265.32±73.09 77 632 841 308.25±91.12 77 671
Open in a new tab

The results of genetic association of the 22 SNPs with the 18 traits are presented in Tables 3a and 3b. In Table 3a, we show the P-values of single-locus association tests with traits that are primarily associated with measures of obesity (Wt, BMI, WC, HC and WHR) and T2D (FPG, HbA1c and insulin). The most notable observations were with the SNPs in FTO and TCF7L2. All 8 FTO SNPs were individually associated with Wt, BMI, WC and HC; 20 of the 32 nominal P-values remained significant after permutation testing. Two FTO SNPs (rs9939973 and rs1121980) were also nominally associated with insulin. The strongest associations were found between the two TCF7L2 SNPs (rs7903146 and rs12255372) and FPG and HbA1c, with P-values (all ≤1 × 10−5) remaining significant after the permutation tests. In addition, rs1801282 (PPARG), rs10811661 (CDKN2A/B) and rs1111875 (HHEX/IDE) were marginally associated with both FPG and HbA1c levels. The HHEX/IDE variant was also nominally associated with Wt and BMI.

Table 3a. P-values of single-locus association tests with traits of primary involvement with obesity and T2D.

SNP Gene Wt BMI WC HC WHR FPG HbA1c Insulin
rs7566605 INSIG2 0.8241 0.6250 0.6983 0.8846 0.4685 0.7412 0.3214 0.3683
rs1801282 PPARG 0.9015 0.9478 0.7123 0.2166 0.4526 0.0463 0.0402 0.8157
rs10946398 CDKAL1 0.4687 0.7888 0.8522 0.8098 0.6234 0.5921 0.0380 0.0809
rs13266634 SLC30A8 0.3859 0.8006 0.5610 0.9760 0.3627 0.7612 0.3965 0.3110
rs564398 CDKN2B 0.2659 0.5976 0.3366 0.3005 0.6022 0.7524 0.8627 0.2888
rs10811661 CDKN2A 0.7389 0.6424 0.3315 0.8007 0.3216 0.0426 0.0336 0.6773
rs1111875 HHEX/IDE 0.0289 0.0413 0.1624 0.2168 0.5880 0.0164 0.0163 0.4383
rs7903146 TCF7L2 0.1785 0.2602 0.3611 0.5749 0.4348 1.29E-07 1.14E-09 0.4202
rs12255372 TCF7L2 0.1930 0.0950 0.2746 0.3026 0.5428 9.62E-08 6.37E-09 0.1310
rs9939973 FTO 0.0024 0.0047 0.0009 0.0139 0.0305 0.9428 0.3743 0.0167
rs1421085 FTO 0.0013 0.0010 0.0004 0.0010 0.1277 0.9686 0.4779 0.0664
rs1121980 FTO 0.0010 0.0013 0.0006 0.0022 0.1169 0.8934 0.5187 0.0457
rs17817449 FTO 0.0009 0.0025 0.0009 0.0021 0.1462 0.5949 0.8865 0.1571
rs8050136 FTO 0.0051 0.0179 0.0026 0.0078 0.1524 0.6895 0.7871 0.1714
rs3751812 FTO 0.0029 0.0064 0.0020 0.0029 0.2310 0.5585 0.9416 0.1086
rs9939609 FTO 0.0018 0.0043 0.0016 0.0063 0.1027 0.5013 0.7326 0.2418
rs7190492 FTO 0.0054 0.0130 0.0009 0.0110 0.0229 0.2070 0.4397 0.0768
rs17782313 MC4R 0.0817 0.3312 0.1987 0.2315 0.5412 0.8683 0.1626 0.5135
rs12970134 MC4R 0.0540 0.1401 0.1414 0.1822 0.4766 0.8727 0.4638 0.9882
rs477181 MC4R 0.2032 0.4211 0.6506 0.1405 0.3210 0.9218 0.4512 0.5074
rs502933 MC4R 0.0961 0.2539 0.3708 0.0711 0.4804 0.9472 0.4479 0.9060
rs4450508 MC4R 0.1356 0.2424 0.3561 0.0918 0.5768 0.8037 0.6887 0.9428
Open in a new tab

Empirical P-values (<0.05) are shown in bold; P-values that maintain significance after permutation tests are underlined.

Table 3b. P-values of single-locus association test with metabolic traits of secondary involvement with obesity and T2D.

SNP Gene DBP SBP HDL LDL TC TG Fibrinogen Calcium Creatinine Uric acid
rs7566605 INSIG2 0.2291 0.7331 0.6855 0.8362 0.6363 0.7372 0.1060 0.1316 0.8093 0.9117
rs1801282 PPARG 0.1928 0.5681 0.2944 0.4522 0.3466 0.1923 0.5983 0.2750 0.3073 0.5802
rs10946398 CDKAL1 0.5244 0.2873 0.1381 0.9542 0.6557 0.7126 0.0085 0.7534 0.2626 0.4152
rs13266634 SLC30A8 0.7711 0.4559 0.6692 0.0740 0.0473 0.7669 0.6007 0.1229 0.5746 0.0160
rs564398 CDKN2B 0.6574 0.2279 0.2422 0.3836 0.3882 0.1684 0.5774 0.3860 0.7380 0.6599
rs10811661 CDKN2A 0.8407 0.1204 0.7581 0.2645 0.3898 0.7571 0.9392 0.4871 0.5388 0.9719
rs1111875 HHEX/IDE 0.9582 0.4485 0.1979 0.4477 0.2921 0.3319 0.4013 0.7220 0.3647 0.5799
rs7903146 TCF7L2 0.7694 0.8916 0.6502 0.5222 0.6610 0.9198 0.5471 0.1897 0.2615 0.9639
rs12255372 TCF7L2 0.9222 0.6293 0.5218 0.6823 0.7637 0.6648 0.2400 0.4415 0.1634 0.9961
rs9939973 FTO 0.1408 0.0927 0.0202 0.3841 0.4224 0.1599 0.0369 0.2461 0.3442 0.2037
rs1421085 FTO 0.1986 0.3867 0.0228 0.3840 0.4475 0.1721 0.0620 0.2077 0.5951 0.2503
rs1121980 FTO 0.2001 0.3761 0.0425 0.2936 0.4192 0.1627 0.1273 0.2662 0.6252 0.2009
rs17817449 FTO 0.2621 0.4452 0.0482 0.6007 0.7767 0.1453 0.0583 0.2830 0.6856 0.3106
rs8050136 FTO 0.1485 0.3353 0.0379 0.6076 0.8816 0.0583 0.0511 0.3911 0.7973 0.3517
rs3751812 FTO 0.2783 0.3822 0.0649 0.4587 0.6521 0.1799 0.0599 0.2399 0.7485 0.4303
rs9939609 FTO 0.3198 0.6684 0.0303 0.4098 0.7927 0.0421 0.0833 0.0530 0.5885 0.2899
rs7190492 FTO 0.0761 0.0358 0.0983 0.3679 0.2185 0.7813 0.0610 0.9017 0.3096 0.2108
rs17782313 MC4R 0.4253 0.3599 0.3851 0.4106 0.5881 0.4449 0.6862 0.7231 0.0237 0.1261
rs12970134 MC4R 0.7060 0.1162 0.3348 0.9171 0.9739 0.1056 0.5220 0.7346 0.1317 0.2670
rs477181 MC4R 0.9406 0.8286 0.8359 0.9309 0.9146 0.9021 0.3465 0.6542 0.5027 0.1809
rs502933 MC4R 0.9499 0.8887 0.6123 0.9957 0.9446 0.8991 0.2029 0.7798 0.4066 0.2404
rs4450508 MC4R 0.8625 0.7548 0.6526 0.8450 0.8617 0.9218 0.3814 0.7657 0.6040 0.5451
Open in a new tab

Empirical P-values (<0.05) are shown in bold.

Table 3b shows the results of single SNP associations with traits that are involved in the larger milieu of metabolic abnormalities and secondarily associated with obesity and T2D. Although the P-values are nominal, six FTO SNPs (rs9939973, rs1421085, rs1121980, rs17817449, rs8050136 and rs9939609) were associated with HDL; rs7190492 in FTO was associated with SBP; rs132266634 in SLC30A8 was associated with TC; rs9939609 in FTO was associated with TG; rs10946398 in CDKAL1 and rs9939973 in FTO were associated with fibrinogen; rs17782313 in MC4R was associated with creatinine; and rs13266634 in SLC30A8 was associated with uric acid.

Discussion

We sought to replicate associations of 22 GWAS variants in 10 gene regions with a series of metabolic traits in an isolated population of European descent. The published studies have provided both direct and indirect explanations of biological plausibility of these genes/regions (INSIG2, PPARG, HHEX/IDE, CDKAL1, SLC30A8, CDKN2A, CDKN2B, TCF7L2, FTO and MC4R) in the pathophysiology of carbohydrate intolerance and the maintenance of energy balance. Our study replicated the associations of FTO and TCF7L2 GWAS SNPs with obesity and T2D-related traits, respectively. The FTO gene variants have shown consistent associations with obesity across several studies.9, 10, 11, 14, 25, 26, 27 These studies primarily considered BMI as the measure of obesity. We extended the list of the phenotypic traits influencing obesity and found without exception, FTO variants were associated with each of the four obesity-related traits (Wt, BMI, WC and HC, with P-values ranging from 0.018 to 0.0004). We found clear replication of previously reported associations of two SNPs, rs3751821 and rs1421085, with Wt and BMI, respectively.14, 28 Overall, the consistent associations between the extended measures of obesity and all eight SNPs provide further evidence that FTO variants influence body fatness. In a recent study, we evaluated association of 29 SNPs on FTO, including the eight variants reported here, with a larger number of obesity-related phenotypic traits.29 In addition to the body fatness measures (BMI, Wt, WC and HC), this study showed that FTO variants influence lean mass (eg, bicondilar upper arm width), suggesting pleiotropic effects of the FTO gene. Also, we found that the body fatness measures were highly correlated (all r2 >0.8),29 which at least partially explain the consistent association of the obesity-related traits with FTO SNPs. However, precise relationships between FTO SNPs and each of the obesity-related traits are difficult to assert from these observations, as the genetic and environmental contributions to their correlations are unknown.

With respect to the risk of T2D, the strongest evidence for association has been found with variants on the TCF7L2 gene with odds ratios >1.5 in multiple studies.1, 2, 30, 31, 32 We genotyped two GWAS SNPs, each showing very strong associations with FPG (rs7903146, P=1.29 × 10−7; rs12255372, P=9.62 × 10−8) and HbA1c (rs7903146, P=1.14 × 10−9; rs12255372, P=6.37 × 10−9). We also performed a secondary analysis of all SNPs taking into consideration FPG and HbA1c as dichotomous traits being surrogates for T2D state (all data not shown). In the total sample of 843 individuals, 113 had FPG ≥126 mg per 100 ml and 100 subjects had HbA1c ≥6.5%, which are cut points for T2D according to the World Health Organization, which are also used as standards for the Croatian populations. We found highly significant associations of the TCF7L2 SNPs with T2D status based on both FPG (rs7903146, P=5.8 × 10−5; rs12255372, P=0.0001) and HbA1c (rs7903146, P=9.93 × 10−6; rs12255372, P=3.33 × 10−5), all P-values remained significant after corrections for multiple tests. In spite of the relatively smaller sample size of our study, these results reiterate the importance of genetic variation in FTO and TCF7L2 influencing the risk of obesity and T2D in our study population.

We found effect size estimates of variants in FTO on measures of body fatness were comparable to those reported in previous GWAS, which reported various FTO SNP effect sizes between 0.33 and 1.45 kg/m2 per risk allele.9, 14, 25, 28 For example, each copy of the C allele of the most significant FTO SNP rs1421085 was associated with an elevation of age and gender adjusted values of Wt (1.98 kg), HC (1.42 cm), WC (1.78 cm) and BMI (0.64 kg/m2). Under the additive model, the variance explained by rs1421085 was 1.22% (Wt), 1.27% (HC), 1.49% (WC) and 1.29% (BMI). An example of this is presented graphically in Supplementary Figure 1 illustrating the comparability of effect sizes (in BMI units) between this study and previously reported GWAS based on rs1421085 and SNPs that are in strong linkage disequilibrium (LD) with this SNP in our population. The effect sizes obtained by Dina et al10 are somewhat larger, which is likely because of their use of morbidly obese individuals in effect size calculations. Importantly, the most significant SNP in our study, rs1421085, overlaps the 95% confidence intervals of SNPs in high LD in the reported GWAS. Similarly, in TCF7L2, each copy of the T allele of rs12255372 corresponded with an elevation of age and gender adjusted values of FPG (0.39 mmol/l) and HbA1c (0.27%). The variance explained by the effect of rs12255372 was 4.4% (FPG) and 4.3% (HbA1c). As noted above, in GWAS FTO and TCF7L2 have emerged as the most important genes influencing the risks for obesity and T2D and have been replicated in populations of diverse origins. Our results of association not only confirmed these findings, but were further augmented by higher effect sizes of the variants, which is likely attributable to a homogenous genetic background of the study population. It should also be noted that the eight FTO SNPs in our study population were in high LD, with average pairwise r2>0.8 and the two TCF7L2 SNPs were in near perfect LD (r2=0.92).

The modest sample size of our study limited the power to detect signals of association of variants of small effect sizes or to provide confirmation of previously reported findings. On the basis of power calculations for 22 SNPs, however, we have sufficient power to detect SNPs with moderate effect size. For example, our study has 94.8% power to detect SNPs, which explain 1.5% variance at the nominal significance level (α=0.05). Even using the multiple-testing adjusted significance level (α=0.05/14, 14 is the estimated number of equivalent independent tests of the 22 SNPs based on permutation), the power is 74.8%. We found nominal replications of the SNPs on PPARG (rs1801282), CDKN2A/B (rs10811661) and HHEX/IDE (rs111875) with both FPG and HbA1c levels. Each of these three SNPs was previously associated with T2D risk in GWAS;4, 7 direction of associations in our study was consistent with these studies. Of note is the PPARG SNP rs1801282, which is the Pro12Ala coding variant and was found to be associated with decreased T2D risk.33 We found the association of this SNP was in the same direction as was found by Altshuler et al;33 the minor allele was protective against T2D when defined by HbA1c ≥6.5%. We did not find association of the variants in the two previously implicated T2D loci, CDKAL1 and SLC30A8, with FPG, HbA1c or insulin levels. Our study failed to confirm the association between variants in MC4R and measures of body fatness. The MC4R SNPs were found to be associated with fat mass, Wt, WC, insulin resistance in previous GWAS.12, 13 We also did not find association of the INSIG2 SNP, rs7566605, with any of the phenotypic traits. This was the first variant implicated in obesity in a GWAS.8 However, its association remains largely inconclusive.34 Failure to replicate these findings, whose effect sizes are small, could have stemmed from insufficient sample size. It should also be noted that the GWAS SNPs may not be the true trait or disease-specific variants, rather these could be in LD with the causal variants. Varied patterns of LD across populations owing to genetic diversity could mask the association of an index SNP with the trait in different populations. We report nominal associations of the GWAS variants with several other metabolic traits, which have not yet been explored in other studies. Therefore, these results need further verification in larger samples of varied ancestries.

Acknowledgments

This study was supported by a grant from the National Institutes of Health, USA (R01 DK069845) and grants from the Croatian Ministry of Science, Education and Sports (196-1962766-2751 to PR, 196-1962766-2747 to NSN, 196-0342282-0291 to ZD). RK was supported by a training grant from the National Institute of Environmental Health Sciences, USA (T32 ES010957). GZ was supported partially by a gift fund from Ellen and the late Dr George Rieveschl Jr.

The authors declare no conflict of interest.

Footnotes

Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)

Author contributions

The study was conceived and designed by RD, PR and RC. Sample and data collection was conducted by NJ, DH-A, SM, NSN, ZD and PR. Genotyping was performed by RK, SRI and GS. Statistical analysis was performed by RK, GZ, WN and RC. The draft paper was prepared by RK, GZ, ZD, NSN, RC, PR and RD. All authors read and approved the final draft.

Supplementary Material

Supplementary Figure 1
Click here for additional data file. (344.3KB, tif)

References

  1. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–885. doi: 10.1038/nature05616. [DOI] [PubMed] [Google Scholar]
  2. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–1345. doi: 10.1126/science.1142382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–1336. doi: 10.1126/science.1142358. [DOI] [PubMed] [Google Scholar]
  4. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–1341. doi: 10.1126/science.1142364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–775. doi: 10.1038/ng2043. [DOI] [PubMed] [Google Scholar]
  6. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type-2 diabetes. Nat Genet. 2007;39:977–983. doi: 10.1038/ng2062. [DOI] [PubMed] [Google Scholar]
  7. The Wellcome Trust Case Control Consortium Genome-wide association study of 14 000 cases of seven common diseases and 3 000 shared controls. Nature. 2007;447:661–678. doi: 10.1038/nature05911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity. Science. 2006;312:279–283. doi: 10.1126/science.1124779. [DOI] [PubMed] [Google Scholar]
  9. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894. doi: 10.1126/science.1141634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–726. doi: 10.1038/ng2048. [DOI] [PubMed] [Google Scholar]
  11. Hinney A, Nguyen TT, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2007;2:e1361. doi: 10.1371/journal.pone.0001361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–775. doi: 10.1038/ng.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40:716–718. doi: 10.1038/ng.156. [DOI] [PubMed] [Google Scholar]
  14. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24. doi: 10.1038/ng.274. [DOI] [PubMed] [Google Scholar]
  15. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007;8:657–662. doi: 10.1038/nrg2178. [DOI] [PubMed] [Google Scholar]
  16. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication idenitifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–645. doi: 10.1038/ng.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rudan P, Roberts DF, Sujoldzic A, et al. Strategy of anthropological research on the island of Hvar. Coll Anthropologicum. 1982;6:39–46. [Google Scholar]
  18. Rudan P, Sujoldzic, Simic D, et al. Population structure in eastern Adriatic: the influence of historical processes, migration patterns, isolation and ecological pressures, and their interactionin Roberts DF, Fujiki N, Torizuka K (eds): Isolation, Migration and Health Cambridge University Press: Cambridge (SSHB)1992204–218. [Google Scholar]
  19. Smolej-Narancic N, Zagar I. Overweight and fatness in Dalmatia, Croatia: comparison with the US population reference. Coll Antropol. 2000;24:411–421. [PubMed] [Google Scholar]
  20. Rudan I, Rudan D, Campbell H, et al. Inbreeding and risk of late onset complex disease. J Med Genet. 2003;40:925–932. doi: 10.1136/jmg.40.12.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pucarin-Cvetkovic J, Mustajbegovic J, Jelinic JD, et al. Body mass index and nutrition as determinants of health and disease in population of Croatian Adriatic islands. Croat Med J. 2006;47:619–626. [PMC free article] [PubMed] [Google Scholar]
  22. Pal P, Xi H, Sun G, et al. Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum Genet. 2007;122:251–259. doi: 10.1007/s00439-007-0394-3. [DOI] [PubMed] [Google Scholar]
  23. National Institutes of Health . National Institutes of Health, NIH Publication No 01-3670, Bethesda, MD; 2001. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [Google Scholar]
  24. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndromeApril2005 , http://www.idf.org/webdata/docs/MetSyndrome_Final.pdf .
  25. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115. doi: 10.1371/journal.pgen.0030115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Grant SF, Li M, Bradfield JP, et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS One. 2008;3:e1746. doi: 10.1371/journal.pone.0001746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Price RA, Li W-D, Zhao H. FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs. BMC Med Genet. 2008;9:4. doi: 10.1186/1471-2350-9-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34. doi: 10.1038/ng.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zhang G, Karns R, Narancic NS, et al. Common SNPs in FTO gene are associated with obesity related anthropometric traits in an island population from the eastern Adriatic coast of Croatia. PLoS One. 2010;5:e10375. doi: 10.1371/journal.pone.0010375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–323. doi: 10.1038/ng1732. [DOI] [PubMed] [Google Scholar]
  31. Cauchi S, El Achhab Y, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85:777–782. doi: 10.1007/s00109-007-0203-4. [DOI] [PubMed] [Google Scholar]
  32. Tong Y, Lin Y, Zhang Y, et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large human genome epidemiology (HuGE) review and meta-analysis. BMC Med Genet. 2009;10:15. doi: 10.1186/1471-2350-10-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80. doi: 10.1038/79216. [DOI] [PubMed] [Google Scholar]
  34. Lyon HN, Emilsson V, Hinney A, et al. The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet. 2007;3:e61. doi: 10.1371/journal.pgen.0030061. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure 1
Click here for additional data file. (344.3KB, tif)

Articles from European Journal of Human Genetics are provided here courtesy of Nature Publishing Group

RESOURCES